Diabetic Kidney Disease&nbsp;
Diabetic kidney disease (DKD), also known as diabetic nephropathy (DN), is a clinical syndrome characterized by persistent albuminuria and a progressive decline in renal function, and the term infers the presence of a typical pattern of glomerular disease. DKD is usually associated with arterial hypertension and increased cardiovascular morbidity and mortality.&nbsp;
The causes of DKD are complex and most likely related to many factors, but the major factor is hyperglycemia. In the early stages, there may not be any symptoms. However, as kidney function decreases further, toxic wastes build up. Consequently, patients often feel sick to their stomachs and throw up, lose their appetites, have hiccups, and gain weight due to fluid retention. If left untreated, patients can develop heart failure and fluid in their lungs.
<a href="https://www.delveinsight.com/report-store/diabetic-kidney-disease-dkd-market">Diabetic Kidney Disease Market</a> Size
The&nbsp;Diabetic Kidney Disease market size was valued ~USD 7.2 billion in 2023 and is anticipated to grow with a significant CAGR furing the study period (2020-2034).
Diabetic Kidney Disease Epidemiological Segmentation
The Epidemiological Segmentation of Diabetic Kidney Disease&nbsp; in 7MM from 2020 to 2034 is segmented as:
&nbsp;
Total prevalent cases of diabetes in the 7MM
<ul>
<li>Total diagnosed prevalent cases of diabetes in the 7MM</li>
<li>Total prevalent cases of DKD in the 7MM</li>
<li>Age-specific cases of DKD in the 7MM</li>
<li>Stage-specific cases of DKD in the 7MM</li>
</ul>
&nbsp;
<a href="https://www.delveinsight.com/report-store/diabetic-kidney-disease-dkd-epidemiology-forecast">Diabetic Kidney Disease Epidemiology</a>
<ul>
<li>The prevalent cases of diabetes in the 7MM comprised approximately 82.9 million cases in 2023 and are projected to increase during the forecast period.</li>
<li>The total prevalent cases of DKD in the 7MM were approximately 33 million in 2023. These cases are expected to increase by 2034</li>
<li>The United States accounted for the highest number of diagnosed prevalent cases of DKD among the 7MM, ~45% of the total cases in 2023.</li>
</ul>
Diabetic Kidney Disease Market Drivers
<ul>
<li>Increasing Prevalence of Diabetes and Aging Population</li>
<li>Advanced Renal Protection Therapies</li>
<li>Government Initiatives and Subsidies</li>
<li>Improved Diagnostic Technology</li>
</ul>
Diabetic Kidney Disease Market Barriers
<ul>
<li>Complex Disease Management Needs</li>
<li>High Treatment Costs</li>
<li>Limited Awareness and Early Screening</li>
<li>Regulatory Challenges for Novel Drugs</li>
</ul>
<a href="https://www.delveinsight.com/report-store/diabetic-kidney-disease-dkd-pipeline-insight">Diabetic Kidney Disease Emerging Drugs</a>
The emerging drugs of the Diabetic Kidney Disease market are
<ul>
<li>REACT&nbsp;</li>
<li>Esaxerenone</li>
<li>SER150&nbsp;</li>
<li>Zibotentan + dapagliflozin&nbsp;</li>
<li>Atrasentan&nbsp;</li>
<li>BI 690517 &plusmn; empagliflozin&nbsp;</li>
<li>Lorundrostat &plusmn; Dapagliflozin&nbsp;</li>
<li>Tozorakimab&nbsp;</li>
<li>VYLEESI&nbsp;</li>
<li>And many others.</li>
</ul>
Diabetic Kidney Disease Key Players
The key players in the Diabetic Kidney Disease market are
<ul>
<li>ProKidney</li>
<li>Daiichi Sankyo</li>
<li>Serodus</li>
<li>Chinook Therapeutics</li>
<li>AstraZeneca</li>
<li>Boehringer Ingelheim</li>
<li>Mineralys Therapeutics</li>
<li>Palatin</li>
<li>Inversago Pharma, And many others.</li>
</ul>

Diabetic Kidney Disease Market

Diabetic Kidney Disease Infographic

Diabetic Kidney Disease Market Size 2034 Infographic

Diabetic Kidney Disease Symptoms, Treatment, epidemiology, companies, drugs infographic is a short guide to understand the problem and market landscape.